PTPRC and ovarian cancer: In our syngeneic ovarian cancer model, FSTL3 overexpression significantly altered the tumor immunocyte composition, by reducing total CD45+ infiltration, and specifically NK cells, B cells, T cells, macrophages, and dendritic cells.